Galapagos (GLPG) Price & Analysis

Compare

545 Followers

GLPG Stock Chart & Stats

Day’s Range― - ―

52-Week Range$22.36 - $33.86

Previous CloseN/A

Volume251.83K

Average Volume (3M)332.58K

Market Cap

$2.15B

Enterprise Value-$1.80B

Total Cash (Recent Filing)$3.09B

Total Debt (Recent Filing)$8.44M

Price to Earnings (P/E)21.2

Beta0.86

Next Earnings

Nov 05, 2025

EPS Estimate

-0.35

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.85

Shares Outstanding65,897,070

10 Day Avg. Volume413,851

30 Day Avg. Volume332,581

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap-0.84

Enterprise Value/Revenue-6.53

Enterprise Value/Gross Profit-12.48

Enterprise Value/Ebitda4.97

Forecast

1Y Price Target

$28.00

Price Target Upside-11.11% Downside

Rating ConsensusHold

Number of Analyst Covering5

Bulls Say, Bears Say

Bulls Say

Financial StabilityThe company expects a cash runway extending to 2028, suggesting financial stability for ongoing projects.

Management And LeadershipThe new management team appears credible and has the right skillsets for the tasks at hand.

Strategic AlternativesGLPG is evaluating strategic alternatives for their CAR-T platform, which is considered a prudent decision.

Bears Say

Clinical FocusThere is caution on GLPG's decision to select MCL as the lead indication for GLPG5101 given the current treatment paradigm.

Competitive LandscapeThere is caution on GLPG's novel CAR-T approach given lack of clear clinical advantages, a tough competitive landscape, and logistical complexity.

Strategic DirectionThe absence of updates on the proposed spinoff indicates uncertainty about the company's strategic direction.

Galapagos News

Galapagos granted RMAT designation to GLPG5101 by FDA

Galapagos (GLPG) announced that the FDA has granted RMAT designation to GLPG5101, a second generation anti-CD19/4-1BB CAR-T product...

6d ago

GLPG

Deutsche Bank downgrades Galapagos to Sell amid ‘too much uncertainty’

Deutsche Bank downgraded Galapagos (GLPG) to Sell from Hold with a price target of EUR 19, down from...

7d ago

GLPG

Galapagos downgraded to Sell from Hold at Deutsche Bank

Deutsche Bank downgraded Galapagos (GLPG) to Sell from Hold with a EUR 19 price target Published first on...

7d ago

GLPG

Galapagos NV Launches New Subscription Right Plan for Management

Galapagos ( ($GLPG) ) has shared an update. On August 7, 2025, Galapagos NV announced the creation of...

5d ago

GLPG

Galapagos NV Secures FDA RMAT Designation for GLPG5101

Galapagos ( ($GLPG) ) has shared an announcement. On August 6, 2025, Galapagos NV announced that the U.S....

6d ago

GLPG

Galapagos Hold Rating: Navigating Management Changes and Strategic Uncertainties

In a report released yesterday, Faisal Khurshid from Leerink Partners reiterated a Hold rating on Galapagos, with a...

18d ago

GLPG

Galapagos NV Reports 2025 Half-Year Results and Strategic Updates

Galapagos NV ( ($GLPG) ) has released its Q2 earnings. Here is a breakdown of the information Galapagos...

19d ago

GLPG

Galapagos NV Reports Strong H1 2025 Results Amid Strategic Transformation

Galapagos ( ($GLPG) ) has issued an announcement. On July 23, 2025, Galapagos NV announced its unaudited financial...

19d ago

GLPG

Galapagos Strengthens Leadership with New Executive Appointments

Galapagos ( ($GLPG) ) has provided an update. On July 23, 2025, Galapagos NV announced the appointment of...

19d ago

GLPG

Galapagos Appoints New Directors to Strengthen Board

An update from Galapagos ( ($GLPG) ) is now available. On July 23, 2025, Galapagos NV announced the...

20d ago

GLPG

Galapagos NV (GLPG) Q2 Earnings Cheat Sheet

Galapagos NV (GLPG) is scheduled to report 2nd quarter earnings on 07/23/2025, after the market closes. Regarding Q2...

22d ago

GLPG

Galapagos NV Appoints Aaron Cox as New CFO

The latest update is out from Galapagos ( ($GLPG) ). On June 23, 2025, Galapagos NV announced the...

2M ago

GLPG

Galapagos CFO Thad Huston to depart, Aaron Cox to succeed

Galapagos (GLPG) announced the appointment of Aaron Cox as CFO, effective July 7. Cox succeeds Thad Huston, who...

2M ago

GLPG

Galapagos Unveils Promising Results for GLPG5101 at ICML 2025

An announcement from Galapagos ( ($GLPG) ) is now available. On June 18, 2025, Galapagos NV presented promising...

2M ago

GLPG

GLPG FAQ

What was Galapagos’s price range in the past 12 months?

Galapagos lowest stock price was $22.36 and its highest was $33.86 in the past 12 months.

What is Galapagos’s market cap?

Galapagos’s market cap is $2.15B.

When is Galapagos’s upcoming earnings report date?

Galapagos’s upcoming earnings report date is Nov 05, 2025 which is in 85 days.

How were Galapagos’s earnings last quarter?

Galapagos released its earnings results on Jul 23, 2025. The company reported -$1.853 earnings per share for the quarter, missing the consensus estimate of -$0.228 by -$1.625.

Is Galapagos overvalued?

According to Wall Street analysts Galapagos’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Galapagos pay dividends?

Galapagos does not currently pay dividends.

What is Galapagos’s EPS estimate?

Galapagos’s EPS estimate is -0.35.

How many shares outstanding does Galapagos have?

Galapagos has 65,897,070 shares outstanding.

What happened to Galapagos’s price movement after its last earnings report?

Galapagos reported an EPS of -$1.853 in its last earnings report, missing expectations of -$0.228. Following the earnings report the stock price went down -7.33%.

Which hedge fund is a major shareholder of Galapagos?

Currently, no hedge funds are holding shares in GLPG

Galapagos Stock Smart Score

Underperform

Fundamentals

Return on Equity

-10.10%

Trailing 12-Months

Asset Growth

-2.53%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Galapagos

Galapagos NV (GLPG) is a biopharmaceutical company headquartered in Mechelen, Belgium. It focuses on the discovery and development of innovative medicines, primarily targeting unmet medical needs in the fields of inflammation, fibrosis, and oncology. The company's core products include various drug candidates in clinical development, with a strong emphasis on using its proprietary target discovery platform to identify new therapeutic targets and develop treatments.

Galapagos (GLPG) Earnings & Revenues

Historic Earnings Reports

GLPG Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call reflects a strong commitment to expanding the clinical pipeline and enhancing manufacturing capabilities, supported by a robust financial position. However, significant restructuring costs and expected high cash burn post-separation highlight ongoing financial challenges.View all GLPG earnings summaries

GLPG Stock 12 Month Forecast

Average Price Target

$28.00

▼(-11.11% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"$21","28":"$28","35":"$35","24.5":"$24.5","31.5":"$31.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$34.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$22.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,24.5,28,31.5,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.71,32.80923076923077,32.90846153846154,33.00769230769231,33.106923076923074,33.206153846153846,33.30538461538462,33.40461538461538,33.503846153846155,33.60307692307693,33.70230769230769,33.80153846153846,33.90076923076923,{"y":34,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.71,32.347692307692306,31.985384615384618,31.623076923076923,31.26076923076923,30.89846153846154,30.536153846153848,30.173846153846153,29.81153846153846,29.44923076923077,29.086923076923078,28.724615384615383,28.36230769230769,{"y":28,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.71,31.886153846153846,31.062307692307694,30.23846153846154,29.414615384615384,28.590769230769233,27.766923076923078,26.943076923076923,26.119230769230768,25.295384615384616,24.47153846153846,23.64769230769231,22.823846153846155,{"y":22,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.89,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.12,"date":1725148800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.5,"date":1727740800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.89,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.99,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.5,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":23,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":26.08,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":24.77,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":26.78,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":29.2,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":27.87,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":32.71,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >